{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T06:46:05Z","timestamp":1709275565480},"reference-count":2,"publisher":"Scientific Scholar","content-domain":{"domain":["ijdvl.com"],"crossmark-restriction":true},"short-container-title":["IJDVL"],"DOI":"10.25259\/ijdvl_754_2022","type":"journal-article","created":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T11:07:32Z","timestamp":1668596852000},"page":"76-76","update-policy":"http:\/\/dx.doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Letter to the editor regarding \u201cEffectiveness and safety of 0.5% timolol solution in the treatment of pyogenic granuloma: A randomised, double-blind and placebo-controlled study\u201d"],"prefix":"10.25259","volume":"89","author":[{"given":"Rochelle Cheryl","family":"Monteiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prajna","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramesh Bhat","family":"Marne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkataram","family":"Mysore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srishti Ravi","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","published-online":{"date-parts":[[2022,11,16]]},"reference":[{"key":"10.25259\/IJDVL_754_2022\/ref-1","doi-asserted-by":"publisher","first-page":"500","DOI":"10.25259\/IJDVL_565_20","article-title":"Effectiveness and safety of 0.5% timolol solution in the treatment of pyogenic granuloma: A randomized, double-blind and placebo-controlled study","volume":"88","author":"Patra","year":"2022","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.25259\/IJDVL_754_2022\/ref-2","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/ijd.13237","article-title":"Is timolol an effective treatment for pyogenic granuloma?","volume":"55","author":"Gupta","year":"2016","journal-title":"Int J Dermotol"}],"container-title":["Indian Journal of Dermatology, Venereology and Leprology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ijdvl.com\/letter-to-the-editor-regarding-effectiveness-and-safety-of-0-5-timolol-solution-in-the-treatment-of-pyogenic-granuloma-a-randomised-double-blind-and-placebo-controlled-study\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ijdvl.com\/letter-to-the-editor-regarding-effectiveness-and-safety-of-0-5-timolol-solution-in-the-treatment-of-pyogenic-granuloma-a-randomised-double-blind-and-placebo-controlled-study\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T11:45:26Z","timestamp":1679312726000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ijdvl.com\/letter-to-the-editor-regarding-effectiveness-and-safety-of-0-5-timolol-solution-in-the-treatment-of-pyogenic-granuloma-a-randomised-double-blind-and-placebo-controlled-study\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,16]]},"references-count":2,"alternative-id":["10.25259\/IJDVL_754_2022"],"URL":"https:\/\/doi.org\/10.25259\/ijdvl_754_2022","relation":{},"ISSN":["0973-3922","0378-6323"],"issn-type":[{"value":"0973-3922","type":"electronic"},{"value":"0378-6323","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,16]]},"article-number":"76"}}